XOMA Chart
See on advanced chart >
About
XOMA Royalty Corporation, a Delaware corporation, discovers and develops innovative antibody-based therapeutics.The company's lead drug candidate is gevokizumab, a humanized antibody that binds to the inflammatory cytokine interleukin-1 beta. The company has...
Read More
- HighlightA biotechnology royalty aggregator that develops antibodies and recombinant proteins to treat infectious and immunological diseases
- ExchangeNASDAQ
- Listing Date06/06/1986
- Established DateInvalid Date
- Full-time Employees13
- Address2200 Powell Street Suite 310 Emeryville California 94608
- Tel1-510-2047200
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Pharmaceuticals